About this trial

The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.

This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.

Eligibility criteria

Qualifiers

18+ years old

Musculoskeletal pathology that may benefit from a PRP injection

Failed other conservative treatments

Disqualifiers

No active malignancy

No active infection in the area of injection

No platelet disorder

No active systemic infections

Trial design

Treatments tested in this trial

  • Platelet Rich Plasma Injection
  • Platelet Rich Plasma Preparation

Treatment groups

10,000 Participants
are divided into 1 treatment group

Locations

1
University of Utah Orthoaedic Center84111-1334, Salt Lake CityUtah, United States

Sponsors and collaborators

University of Utah

Lead sponsor